Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus?

Mastrangelo G, Foeldvari I, Anton J, Simonini G.

Pediatr Rheumatol Online J. 2019 Jul 11;17(1):40. doi: 10.1186/s12969-019-0330-9. Review.

2.

The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis.

Giani T, De Masi S, Maccora I, Tirelli F, Simonini G, Falconi M, Cimaz R.

Front Pharmacol. 2019 Jun 12;10:637. doi: 10.3389/fphar.2019.00637. eCollection 2019.

3.

Is Echocardiography Critical in Patients With Kawasaki Disease With a z Score Less Than 2 to 6 Weeks From Onset?

Maccora I, Calabri GB, Simonini G.

JAMA Pediatr. 2019 May 20. doi: 10.1001/jamapediatrics.2019.1219. [Epub ahead of print] No abstract available.

PMID:
31107498
4.

The First Pediatric Case of Acute Generalized Exanthematous Pustulosis Caused by Hydroxychloroquine.

Liccioli G, Marrani E, Giani T, Simonini G, Barni S, Mori F.

Pharmacology. 2019;104(1-2):57-59. doi: 10.1159/000500406. Epub 2019 May 8.

PMID:
31067554
5.

Clinical Use and Molecular Action of Corticosteroids in the Pediatric Age.

Ferrara G, Petrillo MG, Giani T, Marrani E, Filippeschi C, Oranges T, Simonini G, Cimaz R.

Int J Mol Sci. 2019 Jan 21;20(2). pii: E444. doi: 10.3390/ijms20020444. Review.

6.

Fungal Planet description sheets: 716-784.

Crous PW, Wingfield MJ, Burgess TI, Hardy GESJ, Gené J, Guarro J, Baseia IG, García D, Gusmão LFP, Souza-Motta CM, Thangavel R, Adamčík S, Barili A, Barnes CW, Bezerra JDP, Bordallo JJ, Cano-Lira JF, de Oliveira RJV, Ercole E, Hubka V, Iturrieta-González I, Kubátová A, Martín MP, Moreau PA, Morte A, Ordoñez ME, Rodríguez A, Stchigel AM, Vizzini A, Abdollahzadeh J, Abreu VP, Adamčíková K, Albuquerque GMR, Alexandrova AV, Álvarez Duarte E, Armstrong-Cho C, Banniza S, Barbosa RN, Bellanger JM, Bezerra JL, Cabral TS, Caboň M, Caicedo E, Cantillo T, Carnegie AJ, Carmo LT, Castañeda-Ruiz RF, Clement CR, Čmoková A, Conceição LB, Cruz RHSF, Damm U, da Silva BDB, da Silva GA, da Silva RMF, de A Santiago ALCM, de Oliveira LF, de Souza CAF, Déniel F, Dima B, Dong G, Edwards J, Félix CR, Fournier J, Gibertoni TB, Hosaka K, Iturriaga T, Jadan M, Jany JL, Jurjević Ž, Kolařík M, Kušan I, Landell MF, Leite Cordeiro TR, Lima DX, Loizides M, Luo S, Machado AR, Madrid H, Magalhães OMC, Marinho P, Matočec N, Mešić A, Miller AN, Morozova OV, Neves RP, Nonaka K, Nováková A, Oberlies NH, Oliveira-Filho JRC, Oliveira TGL, Papp V, Pereira OL, Perrone G, Peterson SW, Pham THG, Raja HA, Raudabaugh DB, Řehulka J, Rodríguez-Andrade E, Saba M, Schauflerová A, Shivas RG, Simonini G, Siqueira JPZ, Sousa JO, Stajsic V, Svetasheva T, Tan YP, Tkalčec Z, Ullah S, Valente P, Valenzuela-Lopez N, Abrinbana M, Viana Marques DA, Wong PTW, Xavier de Lima V, Groenewald JZ.

Persoonia. 2018 Dec;40:240-393. doi: 10.3767/persoonia.2018.40.10. Epub 2018 Jul 13.

7.

SAPHO syndrome in pediatric patients with inflammatory bowel disease treated with infliximab.

Marrani E, Belli G, Simonini G, Trapani S, Caproni M, Lionetti P.

Dig Liver Dis. 2018 Nov;50(11):1249-1251. doi: 10.1016/j.dld.2018.09.001. Epub 2018 Sep 12. No abstract available.

PMID:
30274793
8.

Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments.

Marino A, Stagi S, Simonini G, Carli N, Caparello MC, Giani T, Pagnini I, De Masi S, Cimaz R.

Clin Exp Rheumatol. 2018 Sep-Oct;36(5):929-933. Epub 2018 Jul 19.

PMID:
30148444
9.

A misleading case of deficiency of adenosine deaminase 2 (DADA2): the magnifying glass of the scientific knowledge drives the tailored medicine in real life.

Maccora I, Frongia I, Azzari C, Ricci S, Cimaz R, Simonini G.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):146. Epub 2018 Jul 19. No abstract available.

10.

Common symptoms for a rare disease in a girl with sarcoidosis: a case report.

Giovannini M, Luzzati M, Ferrara G, Buccoliero AM, Simonini G, de Martino M, Cimaz R, Giani T.

Ital J Pediatr. 2018 Jun 28;44(1):74. doi: 10.1186/s13052-018-0517-6.

11.

Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.

Cecchin V, Zannin ME, Ferrari D, Pontikaki I, Miserocchi E, Paroli MP, Bracaglia C, Marafon DP, Pastore S, Parentin F, Simonini G, De Libero C, Falcini F, Petaccia A, Filocamo G, De Marco R, La Torre F, Guerriero S, Martino S, Comacchio F, Muratore V, Martini G, Vittadello F, Zulian F.

J Rheumatol. 2018 Aug;45(8):1167-1172. doi: 10.3899/jrheum.171006. Epub 2018 Apr 15.

12.

Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach.

Marrani E, Foeldvari I, Lopez JA, Cimaz R, Simonini G.

Semin Arthritis Rheum. 2018 Dec;48(3):495-503. doi: 10.1016/j.semarthrit.2018.03.003. Epub 2018 Mar 14.

PMID:
29655520
13.

Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.

Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, Gepstein R, Heiligenhaus A, Pilkington CA, Simonini G, Uziel Y, Vastert SJ, Wulffraat NM, Haasnoot AM, Walscheid K, Pálinkás A, Pattani R, Györgyi Z, Kozma R, Boom V, Ponyi A, Ravelli A, Ramanan AV.

Ann Rheum Dis. 2018 Aug;77(8):1107-1117. doi: 10.1136/annrheumdis-2018-213131. Epub 2018 Mar 28.

14.

Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations.

Marino A, Real-Fernández F, Rovero P, Giani T, Pagnini I, Cimaz R, Simonini G.

Clin Rheumatol. 2018 May;37(5):1407-1411. doi: 10.1007/s10067-018-4057-7. Epub 2018 Mar 5.

PMID:
29508177
15.

Joint pain management in children and adolescents.

Marrani E, Maccora I, Giani T, Simonini G, Cimaz R.

Minerva Pediatr. 2018 Feb;70(1):79-97. doi: 10.23736/S0026-4946.17.05137-4. Epub 2017 Nov 21. Review.

PMID:
29160644
16.

Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration.

Simonini G, Ferrara G, Pontikaki I, Scoccimarro E, Giani T, Taddio A, Meroni PL, Cimaz R.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):1046-1051. doi: 10.1002/acr.23435. Epub 2018 Apr 24.

17.

Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.

Simonini G, Bracaglia C, Cattalini M, Taddio A, Brambilla A, De Libero C, Pires Marafon D, Caputo R, Cimaz R.

J Rheumatol. 2017 Jun;44(6):822-826. doi: 10.3899/jrheum.161336. Epub 2017 Apr 1.

PMID:
28365583
18.

Prebiologic Therapy Tuberculosis Screening Experience in a Pediatric Rheumatology Center: TST and IGRA Are Both Necessary.

Marino A, Chiappini E, Cimaz R, Simonini G.

Pediatr Infect Dis J. 2017 Apr;36(4):440-441. doi: 10.1097/INF.0000000000001466. No abstract available.

PMID:
28288085
19.

Pediatric Osteoporosis: Diagnosis and Treatment Considerations.

Marrani E, Giani T, Simonini G, Cimaz R.

Drugs. 2017 Apr;77(6):679-695. doi: 10.1007/s40265-017-0715-3. Review.

PMID:
28271302
20.

Retinal capillaritis in a CRB1-associated retinal dystrophy.

Murro V, Mucciolo DP, Sodi A, Vannozzi L, De Libero C, Simonini G, Rizzo S.

Ophthalmic Genet. 2017 Dec;38(6):555-558. doi: 10.1080/13816810.2017.1281966. Epub 2017 Jan 27.

PMID:
28129017
21.

Mycophenolate mofetil as induction and long-term maintaining treatment in childhood: Primary angiitis of the central nervous system.

Rosati A, Cosi A, Basile M, Brambilla A, Guerrini R, Cimaz R, Simonini G.

Joint Bone Spine. 2017 May;84(3):353-356. doi: 10.1016/j.jbspin.2016.12.004. Epub 2016 Dec 26.

PMID:
28034820
22.

Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status.

Di Paola M, Cavalieri D, Albanese D, Sordo M, Pindo M, Donati C, Pagnini I, Giani T, Simonini G, Paladini A, Lionetti P, De Filippo C, Cimaz R.

Front Microbiol. 2016 Oct 26;7:1703. eCollection 2016.

23.

Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients.

Maggi L, Cimaz R, Capone M, Santarlasci V, Rossi MC, Mazzoni A, Montaini G, Pagnini I, Giani T, Simonini G, Scaletti C, Liotta F, Maggi E, Annunziato F, Cosmi L.

Int Arch Allergy Immunol. 2016;171(1):45-53. Epub 2016 Nov 8.

24.

Surgical abdomen with intestinal pseudo-obstruction as presenting feature of atypical Kawasaki disease.

Trapani S, Montemaggi A, Simonini G, Calabri GB, Messineo A, Resti M.

J Paediatr Child Health. 2016 Nov;52(11):1032-1034. doi: 10.1111/jpc.13284. Epub 2016 Sep 22. No abstract available.

PMID:
27654849
25.

T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies.

Maggi L, Cosmi L, Simonini G, Annunziato F, Cimaz R.

Autoimmun Rev. 2016 Dec;15(12):1141-1144. doi: 10.1016/j.autrev.2016.09.012. Epub 2016 Sep 15. Review.

PMID:
27640318
26.

Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis.

Frid P, Nordal E, Bovis F, Giancane G, Larheim TA, Rygg M, Pires Marafon D, De Angelis D, Palmisani E, Murray KJ, Oliveira S, Simonini G, Corona F, Davidson J, Foster H, Steenks MH, Flato B, Zulian F, Baildam E, Saurenmann RK, Lahdenne P, Ravelli A, Martini A, Pistorio A, Ruperto N; Paediatric Rheumatology International Trials Organisation.

Arthritis Care Res (Hoboken). 2017 May;69(5):677-686. doi: 10.1002/acr.23003.

27.

Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium.

Margheri F, Ceruso M, Carta F, Laurenzana A, Maggi L, Lazzeri S, Simonini G, Annunziato F, Del Rosso M, Supuran CT, Cimaz R.

J Enzyme Inhib Med Chem. 2016;31(sup4):60-63. Epub 2016 Aug 15.

PMID:
27539792
28.

Canakinumab for Childhood Sight-threatening Refractory Uveitis: A Case Series.

Brambilla A, Caputo R, Cimaz R, Simonini G.

J Rheumatol. 2016 Jul;43(7):1445-7. doi: 10.3899/jrheum.160064. No abstract available.

PMID:
27371650
29.

Describing Kawasaki shock syndrome: results from a retrospective study and literature review.

Taddio A, Rossi ED, Monasta L, Pastore S, Tommasini A, Lepore L, Bronzetti G, Marrani E, Mottolese BD, Simonini G, Cimaz R, Ventura A.

Clin Rheumatol. 2017 Jan;36(1):223-228. doi: 10.1007/s10067-016-3316-8. Epub 2016 May 26. Review.

PMID:
27230223
30.

Kawasaki disease: an epidemiological study in central Italy.

Mauro A, Fabi M, Da Frè M, Guastaroba P, Corinaldesi E, Calabri GB, Giani T, Simonini G, Rusconi F, Cimaz R.

Pediatr Rheumatol Online J. 2016 Apr 12;14(1):22. doi: 10.1186/s12969-016-0084-6.

31.

Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis.

Taddio A, Cattalini M, Simonini G, Cimaz R.

Expert Rev Clin Immunol. 2016 Jun;12(6):641-9. doi: 10.1586/1744666X.2016.1146132. Epub 2016 Feb 19. Review.

PMID:
26809126
32.

Erratum to: Successful treatment with adalimumab for severe multifocal choroiditis and panuveitis in presumed (early-onset) ocular sarcoidosis.

Marino A, Pagnini I, Giani T, Caputo R, Arapi I, Neri P, Cimaz R, Simonini G.

Int Ophthalmol. 2016 Feb;36(1):137. doi: 10.1007/s10792-015-0143-x. No abstract available.

PMID:
26500039
33.

The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study.

Marrani E, Cimaz R, Lucherini OM, Caputo R, Vitale A, Cantarini L, Simonini G.

Pediatr Rheumatol Online J. 2015 Oct 6;13(1):38. doi: 10.1186/s12969-015-0037-5.

34.

Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series.

Marrani E, Paganelli V, de Libero C, Cimaz R, Simonini G.

Graefes Arch Clin Exp Ophthalmol. 2015 Oct;253(10):1813-6. doi: 10.1007/s00417-015-3140-x. Epub 2015 Aug 27.

PMID:
26311261
35.

Cupreoboletus (Boletaceae, Boletineae), a new monotypic genus segregated from Boletus sect. Luridi to reassign the Mediterranean species B. poikilochromus.

Gelardi M, Simonini G, Ercole E, Davoli P, Vizzini A.

Mycologia. 2015 Nov-Dec;107(6):1254-69. doi: 10.3852/15-070. Epub 2015 Aug 21.

PMID:
26297785
36.

Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization.

Real-Fernández F, Cimaz R, Rossi G, Simonini G, Giani T, Pagnini I, Papini AM, Rovero P.

Anal Bioanal Chem. 2015 Sep;407(24):7477-85. doi: 10.1007/s00216-015-8915-8. Epub 2015 Jul 26.

PMID:
26210546
37.

Non-anti-TNF biologic modifier drugs in non-infectious refractory chronic uveitis: The current evidence from a systematic review.

Simonini G, Cimaz R, Jones GT, Macfarlane GJ.

Semin Arthritis Rheum. 2015 Oct;45(2):238-50. doi: 10.1016/j.semarthrit.2015.05.006. Epub 2015 May 21. Review.

PMID:
26164255
38.

Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease.

Pagnini I, Bondi T, Simonini G, Giani T, Marino A, Cimaz R.

Rheumatology (Oxford). 2015 Jul;54(7):1327-8. doi: 10.1093/rheumatology/kev197. Epub 2015 May 19. No abstract available.

PMID:
25989957
39.

Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin.

Pagnini I, Simonini G, Cavalli L, la Marca G, Iuliano A, Brandi ML, Bellisai F, Frediani B, Galeazzi M, Cantarini L, Cimaz R.

Pediatr Rheumatol Online J. 2014 Oct 23;12:47. doi: 10.1186/1546-0096-12-47. eCollection 2014.

40.
41.

Current evidence of anti-tumor necrosis factor α treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs.

Simonini G, Druce K, Cimaz R, Macfarlane GJ, Jones GT.

Arthritis Care Res (Hoboken). 2014 Jul;66(7):1073-84. doi: 10.1002/acr.22214. Review.

42.

Does switching anti-TNFα biologic agents represent an effective option in childhood chronic uveitis: the evidence from a systematic review and meta-analysis approach.

Simonini G, Katie D, Cimaz R, Macfarlane GJ, Jones GT.

Semin Arthritis Rheum. 2014 Aug;44(1):39-46. doi: 10.1016/j.semarthrit.2014.03.001. Epub 2014 Mar 6. Review.

PMID:
24709278
43.

Brief report: etanercept inhibits the tumor necrosis factor α-driven shift of Th17 lymphocytes toward a nonclassic Th1 phenotype in juvenile idiopathic arthritis.

Maggi L, Cimaz R, Capone M, Santarlasci V, Querci V, Simonini G, Nencini F, Liotta F, Romagnani S, Maggi E, Annunziato F, Cosmi L.

Arthritis Rheumatol. 2014 May;66(5):1372-7. doi: 10.1002/art.38355.

44.

Anakinra treatment in drug-resistant Behcet's disease: a case series.

Cantarini L, Vitale A, Scalini P, Dinarello CA, Rigante D, Franceschini R, Simonini G, Borsari G, Caso F, Lucherini OM, Frediani B, Bertoldi I, Punzi L, Galeazzi M, Cimaz R.

Clin Rheumatol. 2015 Jul;34(7):1293-301. doi: 10.1007/s10067-013-2443-8. Epub 2013 Dec 5.

PMID:
24305945
45.

Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis.

Pagnini I, Simonini G, Giani T, Marrani E, Moretti D, Vannucci G, Cantarini L, Cimaz R.

Clin Exp Rheumatol. 2014 May-Jun;32(3):408-9. Epub 2013 Nov 14.

PMID:
24238152
46.

Psoriatic juvenile idiopathic arthritis associated with uveitis: a case report.

Moretti D, Cianchi I, Vannucci G, Cimaz R, Simonini G.

Case Rep Rheumatol. 2013;2013:595890. doi: 10.1155/2013/595890. Epub 2013 Sep 29.

47.

Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss.

Berti E, Vannucci G, Lunardi C, Bianchi B, Bason C, Puccetti A, Giani T, Pagnini I, Cimaz R, Simonini G.

Autoimmunity. 2013 Dec;46(8):525-30. doi: 10.3109/08916934.2013.822074. Epub 2013 Aug 15.

PMID:
23944678
48.

Sequential MR angiography in childhood primary angiitis of the CNS.

Rosati A, Pianigiani N, Pagnini I, Guerrini R, Cimaz R, Simonini G.

Pediatr Neurol. 2013 Aug;49(2):127-9. doi: 10.1016/j.pediatrneurol.2012.12.025.

PMID:
23859860
49.

Glucocorticoids in the management of systemic juvenile idiopathic arthritis.

Vannucci G, Cantarini L, Giani T, Marrani E, Moretti D, Pagnini I, Simonini G, Cimaz R.

Paediatr Drugs. 2013 Oct;15(5):343-9. doi: 10.1007/s40272-013-0038-0. Review.

PMID:
23813411
50.

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis.

Simonini G, Taddio A, Cattalini M, Caputo R, de Libero C, Parentin F, Pagnini I, Lepore L, Cimaz R.

Pediatr Rheumatol Online J. 2013 Apr 15;11:16. doi: 10.1186/1546-0096-11-16. eCollection 2013.

Supplemental Content

Loading ...
Support Center